# Andrographis Paniculata vs Boesenbergia Rotunda vs Control in Asymptomatic COVID-19

> **NCT05019326** · PHASE3 · UNKNOWN · sponsor: **Mahidol University** · enrollment: 3060 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Andrographis Paniculata
- **DRUG:** Boesenbergia
- **OTHER:** Standard supportive treatment

## Key facts

- **NCT ID:** NCT05019326
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-30
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 3060 (ESTIMATED)
- **Last updated:** 2021-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05019326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05019326, "Andrographis Paniculata vs Boesenbergia Rotunda vs Control in Asymptomatic COVID-19". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05019326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*